Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 3/20 | 0.55 |
| ▸ | CTSL | P07711 | 3/20 | 0.53 |
| ▸ | CTSS | P25774 | 3/20 | 0.53 |
| ▸ | CTSK | P43235 | 3/20 | 0.53 |
| ▸ | CTSH | P09668 | 1/20 | 0.53 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.53 |
| ▸ | CXCL8 | P10145 | 6/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.53 |
| ▸ | TACR1 | P25103 | 1/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.50 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | NPY4R | P50391 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.50 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11872446 | 0.90 | CASP1 (0.51) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL11872436 | 0.90 | CASP1 (0.51) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL11872216 | 0.89 | GNRHR (0.50) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL3089699 | 0.89 | CXCR4 (0.57) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL3089689 | 0.89 | CXCR4 (0.57) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31208374 | 0.87 | C5AR1 (0.58) | CXCR4CTNNB1TACR1C5AR1KEAP1 | |
| SCHEMBL11867492 | 0.87 | GNRHR (0.51) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL11863142 | 0.87 | IL23R (0.51) | CXCR4CTSLCTSSCTSKCTSH | |
| Teprotide SCHEMBL613590 | 0.87 | F13A1 (0.52) | CXCR4CTSLCTSSCTSKCTSH | |
| Teprotide SCHEMBL11855843 | 0.87 | F13A1 (0.52) | CXCR4CTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395309-A1 | PEPTIDE-DRUG CONJUGATES | HONG KONG BAPTIST UNIVERSITY (CN) | 2021-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395309-A1 | PEPTIDE-DRUG CONJUGATES | BDKRB1, VIP, BDKRB2 | CXCR4 255/4885CTSL 254/4885CTSS 1652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.